Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review

Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review


Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Kyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Co Ltd, is a biotechnology company focused on research and development. It is involved in the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, immunology and allergy, oncology, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, angina pectoris, hypertension, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.

Kyowa Kirin Co Ltd Key Recent Developments

Aug 01,2024: Announcement Regarding the Restructuring of APAC Region Business And Change in a Specified Subsidiary
Jul 29,2024: Kyowa Kirin Joins the Pharmaceutical Supply Chain Initiative (PSCI)
Jun 10,2024: Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Dec 22,2023: Kyowa Hakko Bio Celebrates Grand Opening of Expanded Cognizin Citicoline Manufacturing Facility in Hofu, Japan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Kyowa Kirin Co Ltd - Key Facts
Kyowa Kirin Co Ltd - Key Employees
Kyowa Kirin Co Ltd - Key Employee Biographies
Kyowa Kirin Co Ltd - Major Products and Services
Kyowa Kirin Co Ltd - History
Kyowa Kirin Co Ltd - Company Statement
Kyowa Kirin Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kyowa Kirin Co Ltd - Business Description
Product Category: Licensing Revenue
Performance
Product Category: Products
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other
Performance
R&D Overview
Kyowa Kirin Co Ltd - Corporate Strategy
Kyowa Kirin Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Kyowa Kirin Co Ltd - Strengths
Kyowa Kirin Co Ltd - Weaknesses
Kyowa Kirin Co Ltd - Opportunities
Kyowa Kirin Co Ltd - Threats
Kyowa Kirin Co Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Kyowa Kirin Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 01, 2024: Announcement Regarding the Restructuring of APAC Region Business And Change in a Specified Subsidiary
Jul 29, 2024: Kyowa Kirin Joins the Pharmaceutical Supply Chain Initiative (PSCI)
Jun 10, 2024: Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Dec 22, 2023: Kyowa Hakko Bio Celebrates Grand Opening of Expanded Cognizin Citicoline Manufacturing Facility in Hofu, Japan
Nov 16, 2023: Kyowa Kirin implements Wolters Kluwer Corporate Performance Management solution CCH Tagetik
Aug 03, 2023: Kyowa Kirin Announces Consolidated Financial Results for Six Months Ended June 30, 2023
Jul 11, 2023: Kyowa Kirin Designs New North American Headquarters to Accelerate Innovation, Collaboration, Culture
Jun 28, 2023: Kyowa Kirin Announces Annual Report 2022
May 10, 2023: Kyowa Kirin Announces Appendix to the Consolidated Financial Summary Fiscal 2023 First Quarter
May 10, 2023: Kyowa Kirin announces consolidated financial summary fiscal 2023 Q1
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Kyowa Kirin Co Ltd, Key Facts
Kyowa Kirin Co Ltd, Key Employees
Kyowa Kirin Co Ltd, Key Employee Biographies
Kyowa Kirin Co Ltd, Major Products and Services
Kyowa Kirin Co Ltd, History
Kyowa Kirin Co Ltd, Subsidiaries
Kyowa Kirin Co Ltd, Joint Venture
Kyowa Kirin Co Ltd, Key Competitors
Kyowa Kirin Co Ltd, Ratios based on current share price
Kyowa Kirin Co Ltd, Annual Ratios
Kyowa Kirin Co Ltd, Annual Ratios (Cont...1)
Kyowa Kirin Co Ltd, Annual Ratios (Cont...2)
Kyowa Kirin Co Ltd, Interim Ratios
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Kyowa Kirin Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Kyowa Kirin Co Ltd, Performance Chart (2019 - 2023)
Kyowa Kirin Co Ltd, Ratio Charts
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Kyowa Kirin Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings